Article PDF
References
Bevan DR, Bevan JC, Donati F. Muscle Relaxants in Clinical Anesthesia. Chicago: Year Book Medical Publishers, 1988.
Bourne JG, Collier JOH, Somers GF. Suxamethonium (succinylcholine): muscle-relaxant of short action. Lancet 1952; 1: 1225–9.
Churchill-Davidson IIC. Suxamethonium (succinylcholine) chloride and muscle pains. BMJ 1954; 1: 7–5.
Pinchak AC, Smith CE, Shepard LS, Patterson L. Effect of nondepolarizing muscle relaxants and waiting time on muscle fasciculations after succinylcholine in adult patients. Can J Anaesth 1994; 41: 206–12.
Dottori O, Löf BA, Ygge H. Muscle pains after suxamethonium. Acta Anaesthesiol Scand 1965; 9: 247–56.
Waters DJ, Mapleson WW. Suxamethonium pains: hypothesis and observation. Anaesthesia 1971; 26: 127–41.
Paton WDM. Section of anaesthetics. Proceedings of the Royal Society of Medicine 1951; 45: 185–6.
Hartman GS, Fiamengo SA, Riker WF Jr. Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology 1986; 65: 405–13.
Bowman WC. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 1980; 59: 935–43.
Hatta V, Saxena A, Kaul HL. Phenytoin reduces suxamethonium-induced myalgia. Anaesthesia 1992; 47: 664–7.
Bowman WC, Gibb AJ, Harvey AL, Marshall IG. Prejunctional actions of cholinoceptor agonists and antagonists, and of anticholinesterase drugs.In: Kharkevich DA (Ed.). New Neuromuscular Blocking Agents: Basic and Applied Aspects, Berlin: Springer-Verlag, 1986, 141–70.
Pauca AL, Reynolds RC, Strobel GE. Inhibition of suxemethonium relaxation by tubocurarine and gallamine pretreatment during induction of anaesthesia in man. Br J Anaesth 1975; 47: 1067–73.
Lamoreaux LF, Urbach KF. Incidence and prevention of muscle pain following the administration of succinylcholine. Anesthesiology 1960; 21: 394–6.
White DC. Observations on the prevention of muscle pains after suxamethonium. Br J Anaesth 1962; 34: 332–5.
Paton WDM. The effects of muscle relaxants other than muscle relaxation. Anesthesiology 1959; 20: 453–63.
Gupte SR, Savant NS. Post suxamethonium pains and vitamin C. Anaesthesia 1971; 26: 436–40.
Magee DA, Robinson RJS. Effect of stretch exercises on suxamethonium induced fasciculations and myalgia. Br J Anaesth 1987; 59: 596–601.
Wig J, Bali IM. Relation of precurarization to suxamethonium to provide ease of intubation and to prevent postsuxamethonium muscle pains. Can Anaesth Soc J 1979; 26: 94–8.
Ferres CJ, Mirakhur RK, Craig HJL, Browne ES, Clarke RSI. Pretreatment with vecuronium as a prophylactic against post-suxamethonium muscle pain: comparison with other non-depolarizing neuromuscular blocking drugs. Br J Anaesth 1983; 55: 735–41.
Bennetts FE, Khalil KI. Reduction of post-suxamethonium pain by pretreatment with four non-depolarizing agents. Br J Anaesth 1981; 53: 531–6.
Brodsky JB, Brock-Utne JG. Does “self-tanning” with succinylcholine prevent postoperative myalgia? Anesthesiology 1979; 50: 265–7.
Naguib M, Farag H, Magbagbeola JAO. Effect of pretreatment with lysine acetyl salicylate on suxamethoniuminduced myalgia. Br J Anaesth 1987; 59: 606–10.
Collier C. Suxamethonium pains and fasciculations. Proceedings of the Royal Society of Medicine 1975; 68: 105–8.
Collier CB. Suxamethonium pains and early electrolyte changes. Anaesthesia 1978; 33: 454–61.
Granit R, Skoglund S, Thesleff S. Activation of muscle spindles by succinylcholine and decamethonium. The effects of curare. Acta Physiol Scand 1953: 28: 134–51.
Bowman WC. Pharmacology of Neuromuscular Function, 2nd ed. London: Wright, 1990.
Collier CB. Dantrolene and suxamethonium. The effect of pre-operative dantrolene on the action of suxamethonium. Anaesthesia 1979; 34: 152–8.
McLoughlin C, Nesbitt GA, Howe JP. Suxamethonium induced myalgia and the effect of pre-operative administration of oral aspirin. A comparison with a standard treatment and an untreated group. Anaesthesia 1988; 43: 565–7.
McLoughlin C, Elliott P, McCarthy G, Mirakhur RK. Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens. Anaesthesia 1992; 47: 202–6.
Eisenberg M, Balsley S, Katz RL. Effects of diazepam on succinylcholine-induced myalgia, potassium increase, creatine phosphokinase elevation, and relaxation. Anesth Analg 1979; 58: 314–7.
Laurence AS. Myalgia and biochemical changes following intermittent suxamethonium administration: effects of alcuronium, lignocaine, midazolam and suxamethonium pretreatments on serum myoglobin, creatinine kinase and myalgia. Anaesthesia 1987; 42: 503–10.
Usubiaga JE, Wikinski JA, Usubiaga LE, Molina F. Intravenous lidocaine in the prevention of postoperative muscle pain caused by succinylcholine administration. Anesth Analg 1967; 46: 225–30.
Chatterji S, Thind SS, Dada SR. Lignocaine pretreatment for suxamethonium. A clinicobiochemical study. Anaesthesia 1983; 38: 867–70.
Verma RS, Chatterji S, Mathur N. Diazepam and succinylcholine-induced muscle pains. Anesth Analg 1978; 57: 295–7.
Fahmy NR, Malek NS, Lappas DG. Diazepam prevents some adverse effects of succinylcholine. Clin Pharmacol Ther 1979; 26: 395–8.
Chestnutt WN, Lowry KG, Dundee JW, Pandit SK, Mirakhur RK. Failure of two benzodiazepines to prevent suxamethonium-induced muscle pain. Anaesthesia 1985; 40: 263–9.
Mingus ML, Herlich A, Eisenkraft JB. Attenuation of suxamethonium myalgias: effect of midazolam and vecuronium. Anaesthesia 1990; 45: 834–7.
Pace NL. Prevention of succinylcholine myalgias: a metaanalysis. Anesth Analg 1990; 70: 477–83.
Pace NL. The best prophylaxis for succinylcholine myalgias: extension of a previous meta-analysis (Letter). Anesth Analg 1993; 77: 1080–1.
la Cour D. Rise in intragastric pressure caused by suxamethonium fasciculations. Acta Anaesthesiol Scand 1969; 13: 255–61.
la Cour D. Prevention of rise in intragastric pressure due to suxamethonium fasciculations by prior dose of dtubocurarine. Acta Anaesthesiol Scand 1970; 14: 5–15.
Miller RD, Way WL. Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine. Anesthesiology 1971; 34:185–8.
Dillon JB, Sabawala P, Taylor DB, Gunter R. Action of succinylcholine on extraocular muscles and intraocular pressure. Anesthesiology 1957; 18: 44–9.
Kelly RE, Dinner M, Turner LS, Haik B, Abramson DH, Daines P. Succinylcholine increases intraocular pressure in the human eye with the extraocular muscles detached. Anesthesiology 1993; 79: 948–52.
Meyers EF, Krupin T, Johnson M, Zink H. Failure of nondepolarizing neuromuscular blockers to inhibit succinylcholine-induced increased intraocular pressure, a controlled study. Anesthesiology 1978; 48: 149–51.
Miller RD, Way WL, Hickey RF. Inhibition of succinylcholine-induced increased intraocular pressure by non-depolarizing muscle relaxants. Anesthesiology 1968; 29: 123–6.
Bowen DJ, McGrand JC, Hamilton AG. Intraocular pressure after suxamethonium and endotracheal intubation. The effect of pre-treatment with tubocurarine or gallamine. Anaesthesia 1978; 33: 518–22.
McGoldrick KE. The open globe: is an alternative to succinylcholine necessary? (Editorial). J Clin Anesth 1993; 5: 1–4.
Stirt JA, Grosslight KR, Bedford RF, Vollmer D. “Defasciculation” with metocurine prevents succinylcholineinduced increases in intracranial pressure. Anesthesiology 1987; 67: 50–3.
Minton MD, Grosslight K, Stirt JA, Bedford RF. Increases in intracranial pressure from succinylcholine: prevention by prior nondepolarizing blockade. Anesthesiology 1986: 65: 165–9.
Miller RD, Savarese JJ. Pharmacology of muscle relaxants and their antagonists.In: Miller RD (Ed.). Anesthesia, 3rd ed., New York: Churchill Livingstone Inc., 1990; 389–435.
Stoelting RK, Peterson C. Adverse effects of increased succinylcholine dose following d-tubocurarine pretreatment. Anesth Analg 1975; 54: 282–8.
Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 1975; 43: 89–99.
Erkola O, Salmenperä A, Kuoppamäki R Five non-depolarizing muscle relaxants in precurarization. Acta Anaesth Scand 1983; 27: 427–32.
Sosis M, Broad T, Larijani GE, Man AT. Comparison of atracurium and d-tubocurarine for prevention of succinylcholine myalgia. Anesth Analg 1987; 66: 657–9.
Takki S, Kauste A, Kjellberg M. Prevention of suxamethonium-induced fasciculations by prior dose of d-tubocurarine. Acta Anaesthesiol Scand 1972; 16: 230–4.
Horrow JC, Lambert DH. The search for an optimal interval between pretreatment dose of d-tubocurarine and succinylcholine. Can Anaesth Soc J 1984; 31: 528–33.
Lindgren L, Klemola U-M, Saarnivaara L. Optimal time interval between pretreatment with alcuronium and suxamethonium during anaesthetic induction. Acta Anaesthesiol Scand 1988; 32: 244–7.
Brodsky JB. Why routinely pretreat? (Letter). Anesthesiology 1982; 56: 488–9.
Miller RD. The advantages of giving d-tubocurarine before succinylcholine (Letter). Anesthesiology 1972; 37: 568–9.
Ivankovich AD, Sidell N, Cairoli VJ, Dietz AA, Albrecht RF. Dual action of pancuronium on succinylcholine block. Can Anaesth Soc J 1977; 24: 228–42.
McLoughlin CC, Mirakhur RK, McCarthy GJ. Neuromuscular effects of succinylcholine following different pretreatments. J Clin Anesth 1993; 5: 50–3.
Rogoff RC.Lippman M, Walts LF. An unusual sensitivity to d-tubocurarine. Anesthesiology 1974; 41: 397–8.
Melnick B, Chalasani J, Lim Uy NT, Phitayakorn P, Mallett SV, Rudy TE. Decreasing post-succinylcholine myalgia in outpatients. Can J Anaesth 1987; 34: 238–41.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cannon, J.E. Precurarization. Can J Anaesth 41, 177–183 (1994). https://doi.org/10.1007/BF03009828
Issue Date:
DOI: https://doi.org/10.1007/BF03009828